جست‌وجوی استاد و پژوهشگر

• Molecular Pathology
• Digital Pathology
• Cancer Research
• +۳ مورد دیگر

Jacqueline James is a Clinical Professor and Consultant Pathologist at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences, based at the Patrick G Johnston Centre for Cancer Research. She specializes in Molecular Diagnostics and leads Northern Ireland's first cancer-focused biobank (Northern Ireland Biobank), securing over £3.5 million in funding. Her work supports translational research across cancer, neurodegenerative, respiratory, and infectious diseases. She co-directs the Precision Medicine Centre of Excellence (PMC), focusing on genomics, digital pathology, and big data analytics. James co-leads Queen’s contribution to the UK’s PathLAKE consortium and previously managed a Cancer Research UK Accelerator Programme in Molecular Digital Pathology. Education: Not explicitly listed in the text, but her roles and research suggest advanced qualifications in Pathology and Molecular Biology. Research Interests: Biomarker discovery, tumor microenvironment analysis, digital pathology, multiplex immunofluorescence, and early disease detection. Utilizes tools like QuPath for image analysis. Grants & Funding: Secured £3.5 million for NIB; leveraged over £20 million in competitive grants through NIB. PMC and PathLAKE projects highlight her role in large-scale initiatives. Awards: Includes Excellence in Teaching (2022), Innovation in Teaching Fund (2022), Irish Endocrine Society Award (2022), and the Primary Fellowship Medal (1996). Labs/Teams: Co-leads PMC’s tissue hybridization division and NHS Regional Molecular Diagnostic Service. Active in PathLAKE and Cancer Research UK initiatives. Future Work: Expanding digital pathology applications, AI-driven diagnostics, and precision medicine strategies.

Olof Berglundمشاهده پروفایل

مدرس ارشد

• Ecotoxicology
• Environmental Contaminants
• Ecological Risk Assessment
• +۵ مورد دیگر

Olof Berglund is a Senior Lecturer at the Biology Department of Lund University, Sweden. His primary research focuses on environmental contaminants' transport, uptake, and ecological impacts at population, community, and ecosystem levels. He investigates emerging contaminants such as pharmaceuticals and engineered nanoparticles, aiming to improve ecological risk assessments for anthropogenic chemicals. He coordinates courses like BIOR41 Ecotoxicology and BIOR52 Applied Ecotoxicology, emphasizing practical training for environmental careers. He also teaches VBR 180 Methods in Risk Assessments at LTH, leading the Ecological Risk Assessment module. Recent collaborations span global institutions, with projects addressing metal contamination adaptation in plankton communities and transcriptional biomarkers in bivalves. He has supervised 8 students and contributed to 39 research outputs since 2009. His work aligns with UN Sustainable Development Goals related to clean water and responsible consumption. Research Themes: Contaminant fate/effects, ecological risk assessment, ecotoxicology education Teaching Roles: Course coordinator (BIOR41/BIOR52), Ecological Risk Assessment module lead Key Projects: Future landscapes & metal contamination adaptation (2019–2023) Bivalve toxicity biomarkers (2017–2023) Black Carbon Theme (2011–2012)

Hilal Arnoukمشاهده پروفایل

استاد

• Cancer Immunotherapy
• Biomarker Discovery
• Precision Medicine
• +۳ مورد دیگر

Hilal Arnouk, M.D., Ph.D., is a Professor and Discipline Lead of Pathology at The Chicago School-Illinois College of Osteopathic Medicine . His expertise spans Cancer Immunotherapy, Biomarker Discovery, and Precision Medicine. He has completed education and post-doctoral training at Roswell Park Cancer Institute, SUNY Buffalo, Medical College of Georgia, and University of Alabama at Birmingham. Dr. Arnouk has edited six books, including Biology of T Cells in Health and Disease (2025), Advances in Fine Needle Aspiration Cytopathology (2023), and Advances in Soft Tissue Tumors (2022). These works explore cutting-edge topics in immunology, oncology, and diagnostic pathology. His research emphasizes translating immunological discoveries into clinical therapies, particularly leveraging T cell biology and precision medicine approaches. As an educator, Dr. Arnouk mentors medical and biomedical students, bridging academic and clinical practice. Collaborators include leaders in immunology, such as Thomas Kieber-Emmons and Hendrik-Tobias Arkenau, reflecting his interdisciplinary focus. His contributions to cancer immunology have advanced understanding of T cell mechanisms, biomarker development, and therapeutic innovations.

• Founder CEOs
• Political Ideology
• CEO Succession
• +۴ مورد دیگر

Dr Olga Kalogeraki is a Senior Lecturer in Management and Lead for the MBA in Global Healthcare Management at York Business School, York St John University. She holds a PhD from the University of St.Gallen (Switzerland) and an MSc in Human Resource Management from Brunel University. Her research focuses on CEO political ideology, corporate governance, and gender-related disparities in executive compensation. Her work has been published in high-impact journals like Journal of Management Studies (ABS4*) and Long-Range Planning (ABS3*), and recognized with prestigious awards including EURAM Best Paper Awards in 2018 and 2023. Teaching responsibilities include postgraduate modules such as Global Business Strategy, Sustainable Business, and Organisational Strategy. She currently supervises 15 capstone projects at the postgraduate level. Her research explores intersections between leadership ideology, organizational outcomes, and diversity issues. She is a member of the People in Employment Settings (PiES) research group and has collaborated with institutions like Roche Pharmaceuticals and SBB Switzerland. Key research contributions include examining how CEO and board political ideologies influence corporate misconduct, gender pay gaps, and succession dynamics. Her interdisciplinary approach bridges strategy, international business, and ethics, with a focus on practical implications for organizations.

• Immunology
• Vaccinology
• Microbiology
• +۳ مورد دیگر

Marianne Stanford is an Adjunct Assistant Professor in the Department of Microbiology & Immunology at Dalhousie University's Faculty of Medicine. She is affiliated with the Vaccine Discovery group of the Canadian Centre for Vaccinology and the Beatrice Hunter Cancer Research Institute as an Associate Member. Her research focuses on cancer immunotherapy, vaccine development, and infectious diseases, with expertise in preclinical research and clinical immunology assessments. Education: BSc (Memorial University of Newfoundland), MSc (Memorial University of Newfoundland), PhD (Dalhousie University) Postdoctoral Training: Robarts Research Institute and Ottawa Hospital Research Institute (OHRI) Her research interests include the development of novel cancer treatments using viral therapies, oncolytic virotherapy synergism with signaling inhibitors, and the creation of effective vaccines against infectious diseases like Respiratory Syncytial Virus (RSV). She also holds roles in science policy, including former Chair of the Canadian Association of Postdoctoral Scholars. Dr. Stanford’s recent work emphasizes combination therapies involving immunomodulatory agents and vaccines, with a focus on enhancing T-cell activation and tumor microenvironment modulation. Key areas include the DPX-Survivac immunotherapy for ovarian cancer and lipid-based vaccine formulations. Scientific Awards: None explicitly stated in the provided text. Grants & Labs: Active in translational research through collaborations with institutions like IMV, Inc., and contributes to the Canadian Institute for Health Research (CIHR) as Assistant Scientific Director for the Institute of Infection and Immunity.

• Functional Pharmacogenetics
• Epigenetics
• Drug Metabolism
• +۷ مورد دیگر

Aik Jiang Lau is an Associate Professor at the College of Pharmacy, Dalhousie University, specializing in Functional Pharmacogenetics, Epigenetics, and Drug Metabolism. His research bridges pharmacokinetics and pharmacodynamics to advance personalized pharmacotherapy. BSc (Honours) in Pharmacy, National University of Singapore PhD in Pharmaceutical Sciences, National University of Singapore Postdoctoral Fellowship in Pharmaceutical Sciences and Pharmacology, University of British Columbia His work focuses on genetic and non-genetic factors (e.g., drugs, food, microbiota) regulating drug metabolism and adverse reactions. Key areas include Aldehyde Oxidase Inhibition, Sulfotransferase Enzymology, and Steroid Receptor Pharmacology. From 2016–2022, his publications highlight interactions between drugs, nutraceuticals, and enzymes like CYP3A, SULT2A1, and PXR. Recent studies explore links between steroid hormones and cancer-related cognitive impairment. Postdoctoral Scientist Award - American Society for Pharmacology and Experimental Therapeutics (2012) Emil A. Pfitzer Postdoctoral Award - Society of Toxicology (2012) Best Presentation Award - International Society for the Study of Xenobiotics (2011) Dr. Lau's research team investigates mechanisms to improve drug efficacy and safety, with support from academic and institutional grants. He collaborates with international teams and supervises research trainees in pharmacogenomics and drug metabolism studies.

Jared R. Auclairمشاهده پروفایل

استاد

• Biopharmaceutical Analysis
• Work-Integrated Learning
• Analytical Chemistry
• +۴ مورد دیگر

Jared R. Auclair serves as Dean of the College of Professional Studies and Professor in the Department of Chemistry and Chemical Biology at Northeastern University, with additional affiliations at the Barnett Institute for Chemical and Biological Analysis. His leadership portfolio includes former roles as Vice Provost of Research Economic Development, Director of Bioinnovation, and Associate Dean of Professional Programs and Graduate Affairs at the College of Science. Dr. Auclair's research program centers on work-integrated credentialed learning and use-inspired biopharmaceutical research, emphasizing cross-sector collaboration between academia, industry, and government. His expertise spans analytical characterization of therapeutics, regulatory science, and development of training platforms for biopharmaceutical workforce development, with recent focus on AI integration and virtual reality applications for drug quality assurance. Analysis of his recent publications reveals a dominant trend in applying advanced analytical techniques—particularly mass spectrometry and chromatography—to biopharmaceutical characterization challenges, with growing emphasis on AI-driven solutions for regulatory compliance, gene therapy analysis, and pandemic response tools. His work bridges fundamental science with industry applications across therapeutic proteins, cannabis analysis, and viral vector characterization. Dr. Auclair mentors graduate students through the Biopharmaceutical Analysis Training Laboratory, which partners with industry leaders like Agilent to develop virtual reality training modules and secure collaborative projects with institutions including Loyalist College in Canada for cannabis regulatory analysis. His leadership has established frameworks for STEM education platforms addressing smart biopharmaceutical manufacturing and drug shortage mitigation. The Biopharmaceutical Analysis Training Laboratory operates as an innovation hub for analytical science, featuring collaborations with Agilent on virtual reality drug quality systems and with Canadian institutions on cannabis product analysis. Current initiatives focus on training the next generation of scientists in regulatory-compliant analytical techniques while addressing emerging market challenges in biopharmaceuticals.

• Pharmacognosy
• Natural Products Chemistry
• Phytochemistry
• +۳ مورد دیگر

Graikou Konstantia is a Senior Lecturer and Laboratory Teaching Staff at the Department of Pharmacy, School of Health Sciences, National and Kapodistrian University of Athens. She holds a PhD in Pharmacognosy & Chemistry of Natural Products and has conducted post-doctoral research on Greek endemic plants. Her expertise spans phytochemical analysis, antimicrobial activity assessment, and bioactive compound identification in plants and bee products. Education: Bachelor of Chemistry (1995), Aristotle University of Thessaloniki MSc in Pharmacognosy (1999), University of Athens PhD (2005), University of Athens Post-Doctoral Fellowship (2008–2009), State Scholarships Foundation of Greece Research Interests: Her work focuses on chemical analysis of edible and pharmaceutical plants, phytochemical characterization of Greek endemic species, and evaluation of antimicrobial/antioxidant properties of natural products. Key areas include honey, propolis, royal jelly, and essential oils. Publications: Over 30 peer-reviewed articles, including studies on Greek herbal teas (e.g., Kainari), propolis bioactivity, and the neuropharmacological effects of royal jelly in aging models. Awards: Received the Rector's Prize (2015) from the Medical University of Warsaw for her work on royal jelly's cognitive effects. Recognized for scientific review contributions to journals like Journal of Ethnopharmacology . Teaching & Outreach: Managed the Olympic Games 2004 Doping Control Lab and taught food analysis at the Technological Educational Institute of Athens. Currently leads pharmacognosy laboratory modules at the University of Athens.

• Pulmonary Medicine
• Immunology
• Infectious Diseases
• +۳ مورد دیگر

Hyeon Jun Shin is an Associate Research Scientist in the Department of Pulmonary, Critical Care & Sleep Medicine at Yale School of Medicine. His research focuses on immunology, pulmonary medicine, and molecular pathology, with particular emphasis on mechanisms underlying lung injury, autoimmune diseases, and infectious diseases. He collaborates with experts such as Dr. Brian Clark and Dr. Edward Manning to investigate topics like T helper cell dysfunction, EGFR signaling in lung pathology, and MAVS-mediated immune responses. Key research interests include understanding how genetic deletions (e.g., 17q12) impact immune function, the role of autophagy in hyperoxic lung injury, and developing therapeutic targets for pulmonary fibrosis and viral infections. His work bridges basic science and clinical applications, aiming to translate molecular findings into novel treatments. Recent studies highlight contributions to understanding SARS-CoV-2 pathogenesis, the role of chitinase 3-like-1 in aging-related immunity, and the development of anti-inflammatory peptides targeting TLR pathways. Collaborative efforts with pharmaceutical researchers aim to create novel inhibitors for endosomal TLRs and EGFR pathways. Publications span prestigious journals like EBioMedicine and *AJRCCM Conference Abstracts, reflecting a strong focus on translational research. His work frequently addresses cytokine regulation, mitochondrial dysfunction, and immune checkpoint modulation in respiratory diseases.

Carolyn W.T. Lee-Parsonsمشاهده پروفایل

دانشیار

• Plant Cell Culture
• Pharmaceutical Production
• Bioprocess Engineering
• +۶ مورد دیگر

Carolyn W.T. Lee-Parsons is an Associate Professor in the Chemical Engineering Department and the Chemistry & Chemical Biology Department at Northeastern University's College of Engineering, with additional affiliation in the Bioengineering program. She joined the Chemical Engineering Department in Fall 1999 and leads the Lee-Parsons Lab, which focuses on innovative approaches to pharmaceutical production using plant cell cultures. Education: PhD in Chemical Engineering, Cornell University (1995), Advisor: Prof. Michael L. Shuler BS in Chemical Engineering, University of Kansas, Summa cum laude Dr. Lee-Parsons' research primarily focuses on the production of valuable pharmaceutical compounds from plant cell cultures, specifically targeting the production of important anti-cancer drug molecules like vinblastine and vincristine from Catharanthus roseus (Madagascar periwinkle). Her work bridges chemical engineering, molecular biology, and plant science to develop economically viable processes for producing these complex plant-derived pharmaceuticals. The Lee-Parsons Lab seeks to understand how plant cells regulate the biosynthesis of these critical molecules and then reprograms this regulatory network to increase production using synthetic biology tools like CRISPR technology. Analysis of her recent publications reveals a strong focus on transcription factor regulation of alkaloid biosynthesis in Catharanthus roseus , with particular emphasis on ZCT and GLK transcription factors. Her research increasingly incorporates advanced genome editing techniques to manipulate metabolic pathways, demonstrating a clear progression toward developing practical transformation protocols like EASI for more efficient genetic manipulation of plant systems. This work directly addresses chemotherapy drug shortages by engineering enhanced production of critical plant-derived pharmaceuticals. Scientific Awards: Excellence in Mentoring Award, 2023 College of Engineering Faculty Fellow, 2022 University Excellence in Teaching Award, 2019 Martin W. Essigmann Outstanding Teaching Award, 2013, 2018 Northeastern Research Leadership Development Initiative (ReDI) Program, 2016-2017 National Science Foundation CAREER Award, 2002-2007 Acorn Innovation Grant from MassVentures, 2025 Dr. Lee-Parsons has secured significant research funding from the National Science Foundation, Massachusetts Technology Transfer Center, and GapFund360 to support her work. She actively mentors undergraduate and graduate students, with several mentees receiving PEAK Experiences Awards. Her commitment to education is evident through her teaching awards and development of innovative course modules connecting classroom learning to real-world research, including experiential learning through green chemistry labs and biofuel production analysis. The Lee-Parsons Lab brings together chemical engineers, bioengineers, biochemists, molecular biologists, and plant biologists in a collaborative effort to understand and engineer plant metabolic pathways. The lab's research vision extends beyond cancer drugs to include potential applications in biofuel production using plant or microalgae cultures, demonstrating a broad approach to addressing critical bioproduction challenges through integrated engineering and biological strategies.

Rohini Kunerمشاهده پروفایل

استاد

• Pain Research
• Nervous System Plasticity
• Molecular Pharmacology
• +۳ مورد دیگر

Rohini Kuner serves as Professor and Chair of the Department of Molecular Pharmacology at Heidelberg University's Medical Faculty, Germany, a position held since 2006 with prior directorship of the Institute of Pharmacology (2009-2012). Her academic journey spans international institutions including University of Iowa (PhD) and Max-Planck Institute. Education: 1987-1991: Pharmaceutical Technology, University of Bombay 1994: PhD in Pharmacology, University of Iowa (Supervisor: Prof. G.F. Gebhart) 2005: Habilitation in Pharmacology and Toxicology, Heidelberg University Research Focus: Professor Kuner's work pioneers molecular mechanisms of chronic pain, investigating nervous system plasticity in neurological disorders through neuropharmacological approaches. Her laboratory identifies critical pathways involving calcium signaling, synaptic scaffolding proteins, and tumor-nerve interactions that drive persistent pain states. Publication Trends: Recent works (2013-2009) reveal consistent exploration of inflammatory and cancer pain mechanisms, with emphasis on genomic regulation in spinal neurons, hematopoietic factors in bone pain, and receptor subunit dynamics. These studies bridge molecular discoveries with clinical pain management applications. Scientific Recognition: ERC Advanced Investigator Grant (2011) Pat Wall International Young Investigator Award (2010) National Basic Pain Research Award (2007) Rudolf-Buchheim Prize (2005) Multiple early-career awards (2006-2008) Leadership & Service: As Coordinator of Research Area C in the Excellence Cluster 'CellNetworks', she directs interdisciplinary neuroscience initiatives. Her editorial leadership includes Section Editor for 'Pain' and Associate Editor for 'European Journal of Neuroscience', alongside service on DFG research panels and ERC grant committees.

• Biogerontology
• Geriatric Pharmacology
• Liver and Aging
• +۴ مورد دیگر

Professor David Le Couteur is a distinguished academic and clinician in geriatric medicine at the University of Sydney's Concord Clinical School. He holds roles as a Senior Staff Specialist at Concord Hospital and is affiliated with the ANZAC Research Institute and the Centre for Education and Research on Ageing. His research focuses on biogerontology, liver aging, and geriatric pharmacology, with over 450 peer-reviewed publications and significant grant funding ($30M+). Le Couteur has led editorial roles in top journals like the Journal of Gerontology and served on national committees, including the Pharmaceutical Benefits Advisory Committee. His awards include the AO (2016), FAHMS (2017), and the Ruthven Blackburn Medal (2023). His work spans drug development, aging mechanisms, and translational research, with contributions to dietary interventions and metabolic health in aging populations. Key areas of research include the impact of macronutrients on aging, liver sinusoidal biology, and the role of pharmacological agents like metformin in longevity. His studies often utilize mouse models and human cohort data, such as the Concord Health and Ageing in Men Project (CHAMP), to explore aging-related comorbidities and interventions. Le Couteur's articles highlight themes like nutritional geometry, drug evaluation in aging populations, and molecular mechanisms underlying lifespan. His work bridges basic science and clinical practice, emphasizing the importance of interdisciplinary approaches to address aging-related health challenges. Awards and honors reflect his contributions to pharmacology, geriatric medicine, and health policy. He has been a vocal advocate for deprescribing practices in older adults and has shaped guidelines for medication use in aging populations.

Danila Gurgoneمشاهده پروفایل

مدرس

• Cardiovascular Pharmacology
• Immune Response
• Inflammatory Mechanisms
• +۳ مورد دیگر

Danila Gurgone is a Lecturer in Pharmacology at the School of Cardiovascular & Metabolic Health and an Affiliated Researcher at the School of Infection and Immunity, University of Glasgow. Her research focuses on immune responses in cardiovascular diseases, spanning basic and clinical studies. Gurgone explores immune and inflammatory mechanisms underlying conditions like atherosclerosis, hypertension, and heart failure. Her research interests include: Targeting immune pathways in cardiovascular disorders Inflammatory cytokine networks in vascular diseases Molecular mechanisms of vascular relaxation Nanomedicine approaches for cardiovascular therapeutics Her publications demonstrate cross-disciplinary research integrating pharmacology, immunology, and nanomedicine, with a focus on translational cardiovascular medicine and novel therapeutic strategies.

Leonie Beljaarsمشاهده پروفایل

پژوهشگر

• Liver Fibrosis
• Pharmacology
• Toxicology
• +۳ مورد دیگر

Leonie Beljaars is an External employee in the Faculty of Science and Engineering at the University of Groningen, affiliated with the Pharmaceutical Technology and Biopharmacy department. Her research focuses on liver fibrosis, osteoprotegerin, and inflammatory mechanisms in liver diseases. She contributes to Sustainable Development Goals related to good health and well-being. Her work spans pharmacology, toxicology, and biomedical engineering. Research Interests: Liver fibrosis mechanisms and biomarkers Role of osteoprotegerin and cytokines in liver pathophysiology Biliary atresia and pediatric liver disorders Gene expression in hepatic stellate cells Research Trends: Recent articles emphasize liver inflammation responses, biomarker validation, and comparative studies between human and murine models. Her work bridges basic science with clinical applications in liver disease. Grants & Advising: Supervised 4 works (as noted in her profile). No specific grants mentioned.

• Polymer Chemistry
• Materials Science
• Surface Forces
• +۵ مورد دیگر

Suzanne Giasson is a Full Professor at the University of Montreal, affiliated with both the Faculty of Arts and Sciences (Department of Chemistry) and the Faculty of Pharmacy. Her research focuses on polymer chemistry , surface forces , nanotribology , and stimuli-responsive materials , particularly in soft-matter thin films and biomedical applications. Key affiliations: GRUM (Groupe de recherche universitaire sur le médicament), CQMF (Centre québécois sur les matériaux fonctionnels) Techniques: Surface Forces Apparatus (SFA), Langmuir balance, AFM Applications: Drug delivery, prosthetic coatings, colloidal stability Her research spans 2001-2023 , with a focus on polymer brushes, surface adhesion mechanisms, and nanoscale lubrication. She has supervised 11 doctoral/MSc students and secured 15+ research grants from NSERC, FRQNT, and Mitacs. She received the 2004 Québec Science Discoverers of the Year award for her work on ultra-low friction polymer layers published in Nature . Notable projects include: 2016-2024: Development of multi-responsive surfaces for microfluidics 2017-2023: Independent surface texture/chemistry modulation 2002-2017: Long-term polymer surface property control